There are 2,651 papers on Montreal Cognitive Assessment in aging research: 513 trials and 1,872 observational studies in people, 1 in animals, 166 reviews. The newest story, Nov 19, 2026: “Positive protein test linked to faster movement decline”.
Cognitive training improves Montreal Cognitive Assessment in humans (mild cognitive impairment, community-based group).
“In within-group analyses, the community-based group improved on K-MoCA (p = .015), especially in visuospatial/executive function (p = .033) and delayed recall (p = .019)”
Human trialmild cognitive impairment, community-based groupcommunity-based workbook program12 weeks
Multidomain lifestyle intervention improves Montreal Cognitive Assessment in humans (older adults at risk of decline) (0.58 MoCA points (95% CI 0.03-1.13)).
“Adjusted between-group differences were 0·58 MoCA points (95% CI 0·03-1·13; p = 0·039; Holm-adjusted p = 0·12)”
Human trialolder adults at risk of declinewearable-based multidomain programme of activity, sleep, and optional nutrition prompts6 monthsn = 355
Catheter ablation is linked with better Montreal Cognitive Assessment in humans (patients with atrial fibrillation) (mean difference in change, 0.74 (95% CI, 0.17 to 1.31)).
“Compared with the control group, the ablation cohort demonstrated significantly greater improvements in both MoCA (mean difference in change, 0.74; 95% CI, 0.17 to 1.31; P = .01)”
Humanspatients with atrial fibrillationbrain6 months
Comprehensive cognitive health management programme
↑upin humans1
1 study
Comprehensive cognitive health management programme increases Montreal Cognitive Assessment in humans (mild cognitive impairment) (24.07 (3.674) vs 22.21 (3.052), p=0.002).
“MoCA scores were higher at the 1-year follow-up than at baseline (24.07 (3.674) vs 22.21 (3.052), p=0.002).”
Montreal Cognitive Assessment is linked with eye-hand coordination reaction time in humans (via MoCA; 49.73% of the total effect) (β = 0.18, 95% CI [0.08, 0.30]).
Montreal Cognitive Assessment is linked with higher miscategorization as cognitively impaired in humans (cognitively intact minority ethnic participants) (39.8% vs 0.8%, p < .001).
“the MoCA miscategorised 39.8% of the participants as cognitively impaired, compared to just 0.8% on the RUDAS and the MCE ( p< .001).”
Montreal Cognitive Assessment was not clearly linked with floor and ceiling effects in humans (Patients with Parkinson's disease in Brazil; total score).
“For the total MoCA score, there was no floor or ceiling effect.”
HumansPatients with Parkinson's disease in Brazil; total scoren = 366
Montreal Cognitive Assessment was not clearly linked with vision-related quality of life in humans (1 point less).
“Ten participants (36%) had abnormal MoCA scores, and their VFQ-25 scores were only 1 point less and not statistically different than those with normal MoCA scores”
Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society·
Diagnostic performance for mild cognitive impairment due to Alzheimer's disease
↑upin humans1
1 study
Montreal Cognitive Assessment improves diagnostic performance for mild cognitive impairment due to Alzheimer's disease in humans (Compared with Mini-Mental State Examination in the absence of a gold standard) (Sensitivity: 0.85 versus 0.71; specificity: 0.79 versus 0.71).
“MoCA has greater diagnostic performance than MMSE for differentiating MCI due to AD when the gold standard is absent.”
ReviewCompared with Mini-Mental State Examination in the absence of a gold standard
Metabolic dysfunction-associated steatohepatitis is linked with worse Montreal Cognitive Assessment in older people with HIV (mean MoCA decline of -4.79 (95% CI -7.49 to -2.09) vs -0.94 (95% CI -2.20 to -0.32)).
“Participants with MASH showed a mean MoCA decline of -4.79 (95% CI -7.49 to -2.09), compared with -0.94 (95% CI -2.20 to -0.32) among those without MASH (p-interaction = 0.007).”
Brain free water is linked with Montreal Cognitive Assessment in humans (relationship between SBP and MoCA score) (accounting for 45.04% of the total effect).
“FW partially mediated the relationships of SBP and DBP with MoCA score, accounting for 45.04% and 45.90% of the total effects, respectively.”
Humansrelationship between SBP and MoCA scoren = 984
Bleeding on probing was not clearly linked with Montreal Cognitive Assessment in humans (preliminary analyses in cohort at high risk for AD).
“Preliminary analyses found no significant relationships between bleeding on probing, behavioral factors, SDoH variables, and Montreal Cognitive Assessment (MoCA) scores, which was expected given the small sample size.”
Humanspreliminary analyses in cohort at high risk for ADn = 55
Choroid plexus morphological alterations are linked with Montreal Cognitive Assessment in humans (standardized β = -0.023, 95% CI -0.048 to -0.001).
“The ChP features could act as mediators between AD pathologies and Montreal Cognitive Assessment (standardized β = -0.023, 95% CI -0.048 to -0.001, p = 0.048)”
Humansstatistical mediation between Alzheimer's disease pathologies and cognitive scores in participants without dementiachoroid plexus54.1% femalesn = 564
Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology·
Black and Hispanic race/ethnicity
↓downin humans1
1 study
Black and Hispanic race/ethnicity decreases Montreal Cognitive Assessment in humans (cognitively-normal older adults) (1 to 2 points lower).
“Model-based predictions of median MoCA scores were generally 1 to 2 points lower for Black and Hispanic participants across combinations of age, sex, and education.”
Human trialcognitively-normal older adultsn = 5,338
Montreal Cognitive Assessment predicts mild cognitive impairment in humans (sensitivity 77% (95% CI 76-78), specificity 69% (95% CI 67-69)).
“optimum cutoff scores against NoCI as calculated by the Youden index were less than 24 for detecting MCI, sensitivity 77 % (95% CI, 76‐78), specificity 69 % (95%CI, 67‐69)”
Montreal Cognitive Assessment predicts mild cognitive impairment in humans (South African community sample; compared with RBANS) (AUCs of 0.711 (English) and 0782 (Afrikaans)).
“The MoCA demonstrated fair performance, compared to the RBANS, for predicting MCI, with AUCs of 0.711 (English) and 0782 (Afrikaans).”
HumansSouth African community sample; compared with RBANSn = 370
Montreal Cognitive Assessment predicts cognitive impairment in humans (premorbid-norm definition of impairment, reference standard neuropsychological tests) (≤28/30 captured most impaired participants).
“For premorbid-norms, MoCA was most useful: ≤28/30 captured most impaired participants”
Humanspremorbid-norm definition of impairment, reference standard neuropsychological testsn = 42
Cognitive impairment is associated with Montreal Cognitive Assessment in humans (impaired vs intact cognition determined by MDS) (-5.6 (95% CI: -8.7, -2.4, p=0.0008)).
“In MDS, the mean difference in extracted MoCA was -5.6 (95% CI: -8.7, -2.4, p=0.0008)”
Humansimpaired vs intact cognition determined by MDS60% femalesn = 7,419
Diabetes spectrum : a publication of the American Diabetes Association·
Montreal Cognitive Assessment predicts cognitive impairment in humans (hypertension) (AUC = 0.746).
“The MoCA (AUC = 0.746), the MMSE (AUC = 0.689) and the MiniCog (AUC = 0.684) showed similar ability in detecting cognitive impairment, while the CDT had a poorer discriminative capacity (AUC = 0.535).”
Age is associated with Montreal Cognitive Assessment in humans (community-dwelling very old Blacks/African Americans without dementia) (r = -.406, p = .029).
“higher MoCA score was significantly associated with younger age ( r = ‐.406, p = .029)”
Humanscommunity-dwelling very old Blacks/African Americans without dementian = 29
Montreal Cognitive Assessment predicts dementia in humans (sensitivity 83% (95% CI 82-85), specificity 82% (95% CI 81-83)).
“cutoff scores against NoCI as calculated by the Youden index were less than 21 for detecting dementia, sensitivity 83% (95% CI, 82‐85), specificity 82 % (95% CI, 81‐83).”
Montreal Cognitive Assessment predicts dementia in humans (Screening among residents of the Fez-Meknes region) (Sensitivity 88.5%; specificity 93.8%; Cronbach's alpha 0.87).
“The sensitivity, specificity, and alpha Cronbach of the MoCA test were 88.5, 93.8%, and 0.87”
HumansScreening among residents of the Fez-Meknes regionMoroccan language versions
Montreal Cognitive Assessment is associated with Mini-Mental State Examination in humans (adjusted for age and education) (partial r = .425, p = .027).
“MoCA and MMSE were significantly associated (partial r=.425, p = .027).”
Montreal Cognitive Assessment is associated with Mini-Mental State Examination in humans (chronic renal failure undergoing hemodialysis) (r = 0.69, p = 0.001).
“The results showed a significant positive correlation between MoCA and MMSE (r = 0.69, p = 0.001)”
Montreal Cognitive Assessment is associated with cognitive function in humans (VR-based cognitive assessment (Cogniclear)).
“Significant associations were observed between MoCA scores and VR-derived performance measures, including Global Score, Success Rate, and task duration.”
Montreal Cognitive Assessment is linked with a lower risk of perioperative neurocognitive disorder in diabetic patients undergoing non-cardiac elective surgery (odds ratio, 0.88 [0.8 to 0.97]).
“Multivariate logistic regression analysis showed that the preoperative MoCA was an independent risk factor for PND (odds ratio, 0.88 [0.8 to 0.97]; P = 0.014)”
Humansin diabetic patients undergoing non-cardiac elective surgery
Montreal Cognitive Assessment is associated with navigation efficiency in humans (r=0.495, P=.04).
“navigation efficiency, was significantly influenced by cognitive abilities and was strongly associated with several cognitive tests: the Montreal Cognitive Assessment (r=0.495, P=.04)”
Montreal Cognitive Assessment is associated with navigation efficiency in humans (r = 0.495, p < 0.05).
“navigation efficiency, was significantly influenced by cognitive abilities and strongly correlated with several cognitive tests: the Montreal Cognitive Assessment (r = 0.495, p < 0.05)”
Movement scores worsened by 0.611 points a year in test-positive participants versus 0.139 in test-negative participants followed for up to 12 years.Movement scores worsened by 0.611 points a year in test-positive participants versus 0.139 in test-negative participants followed for up to 12 years.
After 12 weeks, cognitive improvement occurred in 13% with adaptive training across several thinking skills versus 17% with training in fixed skill areas.After 12 weeks, cognitive improvement occurred in 13% with adaptive training across several thinking skills versus 17% with training in fixed skill areas.